Latest News

The EAST-AFNET 4 study provides new evidence on how atrial fibrillation can best be treated in early stages: Therapies that stabilise the heart rhythm can reduce the risk of strokes and severe secondary damage.

Cardiologists from the DZHK partner sites Rhine-Main and Berlin find SARS-CoV-2 in the heart muscle of patients with myocarditis by biopsy - also with overcome COVID-19 disease.

DZHK Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with "gene editing" for the Noonan Syndrome. The results were published in the renowned journal "Circulation".